Researchers at Emory and Northwestern universities have developed artificial intelligence software that can predict the survival of patients diagnosed with glioma, a deadly form of brain tumor, by analyzing digital images of tissue biopsies.
Being able to predict the course of a patient’s glioma at diagnosis is vital given that it carries a bleak prognosis. Gliomas are classified as either low-grade or high-grade based on their appearance under a microscope. The problem is that microscopic examination is extremely subjective, with different pathologists often providing different interpretations.
